Clarivate, a company providing trusted information and insights to accelerate the pace of innovation, completed the acquisition of Bioinfogate, a provider of analytics solutions in the life sciences. Financial terms were not disclosed. "The acquisition of Bioinfogate will further our strategy to become an essential provider of solutions for life science companies along the entire drug development lifecycle. The combined expertise, data and technologies will help customers make smarter and faster evidence-based decisions, boost clinical and commercial success, and bolster our robust integrated platform of life science intelligence solutions from pre-clinical and clinical offerings. Ultimately, the acquisition will deepen the end-to-end value chain from R&D through commercialization and compensation." Mukhtar Ahmed, Clarivate President, Science Group.